The effects of post-treatment with lisofylline, a phosphatidic acid generation inhibitor, on sepsis-induced acute lung injury in pigs

American Journal of Respiratory and Critical Care Medicine

Volumn 155, Issue 3, 1997, Pages 928-936

  Hasegawa, Naoki ^b   Oka, Yoshio ^b   Nakayama, Mitsuo ^b   Berry, Gerald J ^b   Bursten, Stuart ^b   Rice, Glenn ^b   Raffin, Thomas A ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LISOFYLLINE; PHOSPHATIDIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG EFFECT; LUNG HEMODYNAMICS; LUNG INJURY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEPTIC SHOCK; SWINE;

EID: 0030953981     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.155.3.9117028     Document Type: Article

References (45)

1. Fowler, A. A., R. F. Hamman, J. T. Good, K. N. Benson, M. Baird, D. J. Eberle, T. L. Petty, and T. M. Hyers. 1983. Adult respiratory distress syndrome: risk with common predispositions. Ann. Intern. Med. 98:593-597.
2. Montgomery, A. B., M. A. Stager, C. J. Carrico, and L. D. Hudson. 1985. Causes of mortality in patients with the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 132:485-489.
3. Niederman, M. S., and A. M. Fein. 1990. Sepsis syndrome, the adult respiratory distress syndrome, and nosocomial pneumonia: a common clinical sequence. Clin. Chest Med. 11:633-656.
4. Abraham, E., and T. A. Raffin. 1994. Sepsis therapy trials: continued disappointment or reason for hope? J.A.M.A. 271:1876-1878.
5. Bone, R. C., R. A. Balk, A. M. Fein, T. M. Perl, R. P. Wenzel, D. H. Reines, R. W. Quenzer, T. J. Iberti, N. Macintyre, and R. M. H. Schein. 1995. A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. Crit. Care Med. 23:994-1006.
6. Natanson, C., W. D. Hoffman, A. F. Suffredini, P. Q. Eichacker, and R. L. Danner. 1994. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann. Intern. Med. 120: 771-783.
7. Giroir, B. P. 1993. Mediators of septic shock: new approaches for interrupting the endogenous inflammatory cascade. Crit. Care Med. 21:780-789.
8. Rice, G. C., P. A. Brown, R. J. Nelson, J. A. Bianco, J. W. Singer, and S. Bursten. 1994. Protection from endotoxin shock in mice by pharmacologie inhibition of phosphatidic acid. Proc. Natl. Acad. Sci. U.S.A. 91:3857-3861.
9. Bursten, S. L., R. Weeks, J. West, T. Le, T. Wilson, D. Porubek, J. A. Bianco, J. W. Singer, and G. C. Rice. 1994. Potential role for phosphatidic acid in mediating the inflammatory responses to TNF-α and IL-1β. Oc. Shock 44:14-29.
10. Abraham, E., S. L. Bursten, R. Shenkar, J. Allbee, R. Tuder, P. Woodson, D. M. Guidot, G. Rice, J. W. Singer, and J. E. Repine. 1995. Phosphatidic acid signaling mediates lung cytokine expression and lung inflammatory injury after hemorrhage in mice. J. Exp. Med. 181:569-575.
11. Bursten, S. L., W. E. Harris, K. Bomsztyk, and D. Lovett. 1991. Interleukin-1 rapidly stimulates lysophosphatidate acyltransferase and phosphatidate phosphohydrolase activities in human mesangial cells. J. Biol. Chem. 266:20732-20743.
12. Bursten, S. L., W. E. Harris, K. Resch, and D. H. Lovett. 1992. Lipid A activation of glomerular mesangial cells: mimicry of the bioactive lipid, phosphatidic acid. Am. J. Physiol. 161:C328-C338.
13. Guidot, D. M., G. C. Rice, J. W. Singer, S. L. Bursten, J. A. Bianco, E. Abraham, and J. E. Repine. 1994. Inhibition of lyso-phosphatidic acid acyl transferase (LPAAT) activity by CT1501R suppresses neutrophil adherence and chemotaxis in vitro and decreases interleukin-8 (IL-8)-induced injury in isolated rat lungs perfused with human neutrophils (abstract). Clin. Res. 42:145A.
14. English, D., Y. Cui, and R. A. Siddiqui. 1996. Messenger functions of phosphatidic acid. Chem. Physic. Lipid 80:117-132.
15. Singer, J. W., S. L. Bursten, G. C. Rice, W. P. Gordon, and J. A. Bianco. 1994. inhibitors of intracellular phosphatidic acid production: novel therapeutics with broad clinical applications. Exp. Opin. Invest. Drugs 3:631-643.
16. Hasegawa, N., Y. Oka, M. Nakayama, S. Bursten, and T. A. Raffin. 1995. The effects of inhibition of phosphatidic acid generation by lisofylline on sepsis-induced acute lung injury in minipigs (abstract). Am. J. Respir. Crit. Care Med. 151:A764.
17. Lin, H. C., J. C. Thurmon, G. J. Benson, and W. J. Tranquilli. 1993. Telazol - a review of its pharmacology and use in veterinary medicine. J. yet. Pharmacol. Ther. 16:383-418.
18. Mustard, R. A., J. Fisher, S. Hayman, A. Matlow, J. B. M. Mullen, J. Odumeru, M. W. Roomi, B. D. Schouten, and H. P. Swanson. 1989. Cardiopulmonary responses to Pseudomonas septicemia in swine: an improved model of the adult respiratory distress syndrome. Lab. Anim. Sci. 39:37-43.
19. Su, X., A. K. Prestwood, C. M. Otto, D. Prickett, and A. R. McGraw. 1992. Monoclonal antibody to porcine tumor necrosis factor alpha: development of an enzyme-linked immunosorbent assay. J. Immunoassay 13:253-272.
20. Julien, M., M. R. Flick, J. M. Hoeffel, and J. F. Murray. 1984. Accurate reference measurement for postmortem lung water. J. Appl. Physiol. 56:248-253.
21. Doumas, B. T., W. A. Watson, and H. G. Biggs. 1971. Albumin standards and measurement of serum albumin with bromcresol green. Clin. Chim. Acta 31:87-96.
22. Lijana, R. C., and M. C. Williams. 1979. Tetramethylbenzidine: a substitute for benzidine in hemoglobin analysis. J. Lab. Clin. Med. 94: 266-276.
23. Goldblum, S. E., K.-M. Wu, and M. Jay. 1985. Lung myeloperoxidase as a measure of pulmonary leukostasis in rabbits. J. Appl. Physiol. 59:1978-1985.
24. Ohkawa, H., N. Ohishi, and K. Yagi. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95:351-358.
25. Barnard, M. L., S. Gurdian, and J. F. Turrens. 1993. Activated polymorphonudear leukocytes increase low-level chemiluminescence of isolated perfused rat lungs. J. Appl. Physiol. 75:933-939.
26. Kester, M. 1993. Platelet-activating factor stimulates phosphatidic acid formation in cultured rat mesangial cells: roles of phopholipase D, diglyceride kinase, and de novo phospholipid synthesis. J. Cell. Physiol. 156:317-325.
27. Walsh, C. J., P. D. Carey, D. J. Cook, D. E. Bechard, A. A. Fowler, and H. J. Surgerman. 1991. Anti-CD18 antibody attenuates neutropenia and alveolar capillary-membrane injury during gram-negative sepsis. Surgery 110:205-212.
28. Windsor, A. C. J., C. J. Walsh, P. G. Mullen, D. J. Cook, B. J. Fisher, C. R. Blocher, S. K. Leeper-Woodford, H. J. Surgerman, and A. A. Fowler. 1993. Tumor necrosis factor-α blockade prevents neutrophil CD18 receptor upregulation and attenuates acute lung injury in porcine sepsis without inhibition of neutrophil oxygen radical generalion. J. CHn. Invest. 91:1459-1468.
29. Stephens, K. E., A. Ishizaka, J. W. Larrick, and T. A. Raffin. 1988. Tumor necrosis factor causes increased pulmonary permeability and edema. Am. Rev. Respir. Dis. 137:1364-1370.
30. Wang, W., Y. Suzuki, T. Tanigaki, D. R. Rank, and T. A. Raffin. 1994. Effects of NADPH oxidase inhibitor apocynin on septic lung injury in guinea pigs. Am. J. Respir. Crit. Care Med. 150:1449-1452.
31. Rice, G. C., J. Rosen, R. Weeks, J. Michnick, S. Bursten, J. A. Bianco, and J. W. Singer. 1994. CT-1501R selectively inhibits induced inflammatory monokines in human whole blood ex vivo. Shock 1: 254-266.
32. Westlin, W. F., J.-M. Kiely, and M. A. Gimbrone, Jr. 1992. Interleukin-8 induces changes in human neutrophil actin conformation and distribution: relationship to inhibition of adhesion to cytokine-activated endothelium. J. Leukoc. Biol. 52:43-51.
33. Rigings, P. C., A. C. J. Windsor, H. J. Surgerman, E. Kennedy, M. M. Sholley, C. R. Blocher, B. J. Fisher, and A. A. Fowler. 1994. Beneficial cardiopulmonary effects of pentoxifylline in experimental sepsis are lost once septic shock is established Arch. Surg. 129:1144-1152.
34. Cavaillon, J.-M., C. Munoz, C. Fitting, B. Misset, and J. Carlet. 1992. Circulating cytokines: the tip of the iceberg? Circ. Shock 38:145-152.
35. Worthen, G. S., B. Schwab, III, E. L. Elson, and G. P. Downey. 1989. Mechanics of stimulated neutrophils: cell stiffening induces retention in capillaries. Science 245:183-186.
36. Ulich, T. R., J. del Castillo, M. Keys, G. A. Granger, and R.-X. Ni. 1987. Kinetics and mechanisms of recombinant human interleukin-1 and tumor necrosis factor-α-induced changes in circulating numbers of neutrophils and lymphocytes. J. Immunol. 139:3406-3415.
37. Clarke, E., G. C. Rice, R. S. Weeks, N. Jenkins, R. Nelson, J. A. Bianco, and J. W. Singer. 1996. Lisofylline inhibits transforming growth factor-β release and enhances trilineage hematopoietic recovery after 5-fluorouracil treatment in mice. Cancer Res. 56:105-112.
38. 1 in a septic porcine model of adult respiratory distress syndrome. J. Trauma 29: 284-291.
39. Hangen, D. H., R. J. Bloom, J. H. Stevens, P. T. O'Hanley, M. Ranchod, J. A. Collins, and T. A. Raffin. 1987. Adult respiratory distress syndrome: a live E. coli septic primate model. Am. J. Pathol. 126:396-400.
40. Byrne, K., C. N. Sessler, D. P. Carey, T. D. Sielaff, A. Vasquez, J. L. Tatum, J. I. Hirsch, and H. J. Sugerman. 1991. Platelet-activating factor in porcine Pseudomonas acute lung injury. J. Surg. Res. 50:111-118.
41. Brigham, K. L., K. Kariman, T. R. Harris, J. R. Snapper, G. B. Bernard, and S. L. Young. 1983. Correlation of oxygenation with vascular permeability-surface area but not with lung water in humans with acute respiratory failure and pulmonary edema. J. Clin. Invest. 72: 339-349.
42. Snapper, J. R., A. A. Hutchinson, M. L. Ogletree, and K. L. Brigham. 1983. Effects of cyclooxygenase inhibitors on the alterations in lung mechanics caused by endotoxemia in the unanesthetized sheep. J. Clin. Invest. 72:63-76.
43. Hoffmann, H., J. R. Hatherill, J. Crowley, H. Harada, M. Yonemaru, H. Zheng, A. Ishizaka, and T. A. Raffin. 1991. Early post-treatment with pentoxifylline or dibutyryl cAMP attenuates Escherichia coli-induced acute lung injury in guinea pigs. Am. Rev. Respir. Dis. 143:289-293.
44. Novogrodsky A., A. Vanichkin, M. Patya, A. Gazit, N. Osherov, and A. Levitzki. 1994. Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors. Science 264:1319-1322.
45. Tanigaki, T., Y. Suzuki, D. Heimer, W. Wang, H. H. Sussman, W. G. Ross, G. A. Murphy, H. Ikeda, and T. A. Raffin. 1994. The protein kinase C inhibitor, H-7, induces acute lung injury in guinea pigs. Crit. Care Med. 22:1167-1173.